Blue Jet Healthcare Limited (NSE:BLUEJET)
India · Delayed Price · Currency is INR 542.00
+3.95 (0.73%)
Oct 1, 2026, 3:29 PM IST
Blue Jet Healthcare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 102,550 | 56,767 | 153,491 | 66,420 | - | - | |
Market Cap Growth | -6.18% | -63.02% | 131.09% | - | - | - |
Enterprise Value | 99,737 | 52,860 | 149,858 | 63,611 | - | - |
Last Close Price | 541.80 | 326.57 | 881.45 | 380.70 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 40.02 | 22.91 | 50.29 | 40.56 | - | - |
Forward PE | 30.85 | 20.98 | 48.10 | 29.89 | - | - |
PS Ratio | 11.58 | 5.99 | 14.90 | 9.33 | - | - |
PB Ratio | 7.54 | 4.17 | 13.55 | 7.86 | - | - |
P/TBV Ratio | 7.55 | 4.18 | 13.55 | 7.86 | - | - |
P/FCF Ratio | 89.42 | 49.50 | - | 97.11 | - | - |
P/OCF Ratio | 30.69 | 16.99 | 335.40 | 27.53 | - | - |
PEG Ratio | - | 1.57 | 1.20 | 1.42 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 11.26 | 5.58 | 14.55 | 8.94 | - | - |
EV/EBITDA Ratio | 36.20 | 17.99 | 39.86 | 27.96 | - | - |
EV/EBIT Ratio | 39.71 | 19.22 | 41.63 | 31.63 | - | - |
EV/FCF Ratio | 86.97 | 46.09 | - | 93.00 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.02 | 0.00 | 0.01 | 0.03 |
Debt / EBITDA Ratio | 0.15 | 0.14 | 0.05 | 0.01 | 0.02 | 0.07 |
Debt / FCF Ratio | - | 0.37 | - | 0.02 | 0.04 | 0.14 |
Net Debt / Equity Ratio | -0.21 | -0.21 | -0.23 | -0.36 | -0.37 | -0.29 |
Net Debt / EBITDA Ratio | -1.04 | -0.96 | -0.70 | -1.35 | -1.17 | -0.61 |
Net Debt / FCF Ratio | - | -2.45 | 7.76 | -4.49 | -3.05 | -1.22 |
Asset Turnover | - | 0.62 | 0.83 | 0.74 | 0.92 | 1.09 |
Inventory Turnover | - | 1.97 | 2.38 | 2.51 | 2.97 | 2.65 |
Quick Ratio | - | 2.97 | 2.50 | 2.43 | 2.85 | 2.29 |
Current Ratio | - | 4.21 | 3.93 | 3.43 | 3.83 | 3.14 |
Return on Equity (ROE) | - | 19.88% | 30.86% | 21.45% | 26.60% | 42.16% |
Return on Assets (ROA) | - | 11.24% | 18.17% | 13.09% | 15.39% | 22.76% |
Return on Invested Capital (ROIC) | 17.33% | 21.06% | 38.46% | 30.90% | 35.84% | 51.23% |
Return on Capital Employed (ROCE) | - | 19.50% | 31.00% | 23.60% | 28.20% | 42.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.29% | 4.37% | 1.99% | 2.46% | - | - |
FCF Yield | 1.12% | 2.02% | -0.22% | 1.03% | - | - |
Dividend Yield | 0.22% | 0.37% | 0.14% | 0.26% | - | - |
Payout Ratio | - | 8.40% | 5.68% | 0.00% | 0.00% | 0.00% |
Total Shareholder Return | 0.22% | 0.37% | 0.14% | 0.26% | - | - |